The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Astellas Pharma
Enfortumab vedotin (EV) in triple-negative breast cancer (TNBC) and HR+/HER2- breast cancer (BC) cohorts of EV-202.
 
Antonio Giordano
Consulting or Advisory Role - Pfizer; Pfizer
 
Arif Ali Ali Awan
Honoraria - Apotex; AstraZeneca Canada; Exactis Innovation; Lilly; Lilly; Lilly; Novartis; Oncology Education; Roche Canada; Roche Canada
Consulting or Advisory Role - AstraZeneca; AstraZeneca Canada; Exact Sciences; Exact Sciences; Foundation Medicine; Gilead Sciences; Lilly; Lilly; Novartis Canada Pharmaceuticals Inc; Novartis Canada Pharmaceuticals Inc; Pfizer; Pfizer; Roche Canada
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Canexia Health (Inst); Exactis Innovation (Inst); Intensity Therapeutics (Inst); Roche (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Roche/Genentech; Roche/Genentech
 
Justine Yang Bruce
Stock and Other Ownership Interests - ImageMoverMD (I)
Consulting or Advisory Role - Kura Oncology; Lilly; Merck
Research Funding - Astellas Pharma (Inst); Incyte (Inst); Kura Oncology (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst)
 
Hope S. Rugo
Consulting or Advisory Role - Daiichi Sankyo; Eisai; Mylan; Napo Pharmaceuticals; Puma Biotechnology
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Daiichi Sankyo (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Hoffmann-La Roche AG/Genentech, Inc (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Stemline Therapeutics (Inst); Taiho Oncology (Inst); Veru (Inst)
 
Jennifer Robinson Diamond
Leadership - OnKure (Inst)
Stock and Other Ownership Interests - OnKure
Consulting or Advisory Role - Gilead Sciences (Inst)
Research Funding - Adlai Nortye (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Cosmo Pharmaceuticals (Inst); Deciphera (Inst); Gilead Sciences (Inst); Merck (Inst); OnKure (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - OnKure
 
Yelena Novik
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Research Funding - Stemline, Novartis, Innunomedics
 
Joaquina Celebre Baranda
Stock and Other Ownership Interests - Aprea Therapeutics; Merus NV; Moderna Therapeutics; Zymeworks
Research Funding - Astellas Pharma (Inst); Chungchun Intellicrown (Inst); Exelixis (Inst); IMPAC Medical Systems (Inst); Merck (Inst); Poseida (Inst); Sanofi (Inst); Synermore (Inst); Xencor (Inst)
 
Kei Muro
Honoraria - Bristol-Myers Squibb; Daiichi Sankyo/UCB Japan; Lilly; MSD; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Chugai Pharma; Ono Pharmaceutical
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Chugai Pharma (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); PAREXEL International (Inst); PRA Health Sciences (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst)
 
Makiko Ono
Speakers' Bureau - Chugai, Ono pharmaceutical, Gilead
Research Funding - Pfizer, Eisai, Astellas
 
Rita Nanda
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Exact Sciences; GE Healthcare; Gilead Sciences; Guardant Health; Merck; Moderna Therapeutics; Novartis; Sanofi; Seagen; Stemline Therapeutics
Research Funding - Arvinas (Inst); AstraZeneca (Inst); Celgene (Inst); Corcept Therapeutics (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Merck (Inst); OBI Pharma (Inst); Odonate Therapeutics (Inst); OncoSec (Inst); Pfizer (Inst); Relay Therapeutics (Inst); Seagen (Inst); Sun Pharma (Inst); Taiho Oncology (Inst)
Other Relationship - G1 Therapeutics
 
Jason Kaplan
No Relationships to Disclose
 
Seema Rao Gorla
Employment - Astellas Pharma
Research Funding - Astellas Pharma
Travel, Accommodations, Expenses - Astellas Pharma
 
Shubin Liu
No Relationships to Disclose
 
Michele Wozniak
No Relationships to Disclose
 
Anthony Lee
Employment - Pfizer; Roche/Genentech; Seagen
Stock and Other Ownership Interests - Pfizer; Roche/Genentech; Seagen
Patents, Royalties, Other Intellectual Property - U.S. Provisional Patent Application No. 17/159,128 Title: Methods for treatment of cancer with an ANTI-TIGIT antagonist antibody
 
Tiffany A. Traina
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Exact Sciences; G1 Therapeutics; Genentech/Roche; Gilead Sciences; GlaxoSmithKline; Hengrui Pharmaceutical; Merck; Pfizer; Stemline Therapeutics; Tersera
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Ayala Pharmaceuticals (Inst); Daiichi Sankyo (Inst); Genentech/Roche (Inst); Pfizer (Inst)